Lykos Therapeutics (formerly MAPS PBC)
Kristin Rand is a seasoned legal and compliance professional with extensive experience in the pharmaceutical and healthcare sectors. Recent roles include serving as Interim General Counsel and Chief Compliance Officer at Lykos Therapeutics and previously as Chief Compliance Officer and Head of Risk at Resilience. Kristin has contributed to the field through editorial work at Policy & Medicine Compliance Update since 2015 and held prominent positions at Moderna as Head of Corporate Compliance and Global Risk Officer, and at Seattle Genetics as Vice President and Compliance Officer. Kristin's educational background includes a Bachelor of Science in Diagnostic Genetic Sciences from the University of Connecticut and a Juris Doctor from Quinnipiac University School of Law.
This person is not in any teams
This person is not in any offices
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.